Skip to main content

The Microenvironment and Beyond: Novel Targets in Gynecologic Malignancies

  • 916

    Total downloads

  • 4,933

    Total views and downloads

About this Research Topic

Submission deadlines

  1. Manuscript Extension Submission Deadline 22 November 2026

Background

The tumor microenvironment (TME) is increasingly recognized as a dynamic determinant of progression, metastasis, and therapeutic resistance in gynecologic malignancies. This complex ecosystem—comprising immune cells, cancer-associated fibroblasts, vasculature, and extracellular matrix—can limit treatment efficacy while also offering therapeutic opportunities. Moving beyond an exclusive focus on canonical tumor-intrinsic drivers, an important research frontier involves targeting the crosstalk between tumor cells and their surrounding milieu.

This Research Topic seeks to highlight the pivotal role of the TME, alongside other emerging, non-canonical targets, in reshaping the treatment landscape for ovarian, endometrial, cervical, and other gynecologic cancers. We aim to curate a collection of research examining how therapeutic strategies directed at the TME and related pathways may overcome resistance and improve patient outcomes. By focusing on the ecosystem that sustains tumors, this Research Topic will help inform the development of multi-targeted, combinatorial therapies.

The aim of this Research Topic is to provide a dedicated platform for advances in understanding and therapeutically exploiting the tumor microenvironment and other novel biological targets in gynecologic cancers. We welcome submissions that dissect the components of the TME, elucidate their pro-tumorigenic functions, and translate these insights into innovative therapeutic strategies.

The scope of this Research Topic includes, but is not limited to, the following themes:

• The Cellular TME: Investigations into the role and targeting of tumor-associated macrophages (TAMs), cancer-associated fibroblasts (CAFs), tumor-infiltrating lymphocytes (TILs), and myeloid-derived suppressor cells (MDSCs).
• The Physical and Soluble TME: Research focusing on the extracellular matrix (ECM), stiffness, hypoxia, angiogenesis, and key chemokine/cytokine networks.
• Metabolic Crosstalk: Studies exploring metabolic adaptations and dependencies of tumor and stromal cells within the TME.
• Mechanisms of Resistance: Elucidating how the TME confers resistance to conventional chemotherapy, radiotherapy, and targeted agents.
• Beyond the TME: Discovery and validation of other novel targets, including neoantigens, oncogenic viruses, non-coding RNAs, and epigenetic regulators.
• Biomarkers and Patient Stratification: Identification of TME-based biomarkers (e.g., spatial transcriptomics, multiplex immunohistochemistry) to predict response to therapy.
• Combination Therapies: Preclinical and clinical studies on rational combinations of TME-targeting agents with immunotherapy, targeted therapy, or standard-of-care treatments.
• Translation to Clinical Practice: Reports from clinical trials evaluating novel agents that target the TME or other emerging pathways.

Therapeutic Targeting of the TME:
o Strategies to re-educate the immune landscape (e.g., overcoming T-cell exhaustion)
o Agents targeting CAF activation, ECM remodeling, or angiogenesis
o Novel drug delivery systems designed to penetrate and modulate the TME

We invite submissions that advance understanding of the TME and other emerging targets and that open new avenues for treating gynecologic malignancies.




Please note: Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo, which are not based on public databases) are not suitable for publication in this journal.

Research Topic Research topic image

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Clinical Trial
  • Editorial
  • FAIR² Data
  • Hypothesis and Theory
  • Methods
  • Mini Review
  • Opinion

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Tumor microenvironment (TME), Gynecologic malignancies (ovarian, endometrial, cervical), Cancer-associated fibroblasts and immune modulation (CAFs, TAMs, TILs, MDSCs), ECM remodeling, hypoxia, and angiogenesis, Therapeutic resistance and combination thera

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 4,933Topic views
  • 2,291Article views
  • 916Article downloads
View impact